leisure time -WSS

leisure time

author：entertainment 2025-10-02 07:45:08 - browse：273

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： How many hemophilia patients actually want gene therapy?

entertainment

WSS

Pushing for an NIH office for post

Roche's accidental data boosts hopes for anti

WuXi out of biotech trade group, U.S. and China relations to blame

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

President Biden's budget: Here's what you might have missed

John Green on his newest strategy for fighting tuberculosis

focus

leisure time

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

EPA limits use of carcinogenic gas for sterilizing medical devices

Apple is now the first public company to be valued at $3 trillion

Roche's accidental data boosts hopes for anti

Virginia high school admissions case could be legal follow

Readout Newsletter: CAR

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Medical records are filled with copy

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

explore

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Wegovy improves function in certain heart failure patients

First U.S. drug developed to treat liver disease MASH is approved

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Can U.S. cancer drug shortages be fixed?

leisure time

entertainment

leisure time

entertainment